Metabolica eLBP
Type 2 Diabetes & NAFLD/NASH (chronic therapy)
PreclinicalActive
Key Facts
Indication
Type 2 Diabetes & NAFLD/NASH (chronic therapy)
Phase
Preclinical
Status
Active
Company
About Metabolica Health
Microbiome‑driven 4‑cresol platform targeting regenerative metabolic disease.
View full company profile